BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20699041)

  • 1. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
    Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
    Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
    Bosque López MJ; Garrido Durán C; Ginard Vicens D; Munar Vila MA; Vanrell Garau M; Mariño Méndez Z; Gayà Cantallops J
    Gastroenterol Hepatol; 2009 Jan; 32(1):29-31. PubMed ID: 19174096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
    Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic interstitial nephritis and mesalazine: 3 new cases?].
    Brouillard M; Gheerbrant JD; Gheysens Y; Fleury D; Devred M; Hazzan M; Colombel JF
    Gastroenterol Clin Biol; 1998; 22(8-9):724-6. PubMed ID: 9823562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal involvement in patients with chronic inflammatory intestinal disease treated with mesalazine. How to prevent its nephrotoxicity?].
    Bonet J; Vaquero M; Bayés B; Romero R
    Med Clin (Barc); 1999 Jul; 113(5):199. PubMed ID: 10480148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute interstitial nephritis due to mesalazine.
    Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
    Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstitial nephritis induced by mesalazine].
    Ohya M; Otani H; Kimura K; Kodama N; Minami Y; Liang XM; Maeshima E; Yamada Y; Mune M; Yukawa S
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):414-9. PubMed ID: 12073628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory intestinal disease and nephritis].
    Behrens R; Ruder H
    Klin Padiatr; 1992; 204(1):61-4. PubMed ID: 1346814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
    Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
    Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
    [No Abstract]   [Full Text] [Related]  

  • 11. Interstitial nephritis from mesalazine: case report and literature review.
    Arend LJ; Springate JE
    Pediatr Nephrol; 2004 May; 19(5):550-3. PubMed ID: 15007714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between membranous glomerulonephritis and Crohn's disease].
    Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
    Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Crohn's enteritis and chronic tubulo-interstitial nephropathy in an adolescent].
    Larchet M; Guillot M; Mandard JC; Boutard P; Alibert L; Delmas P; Duhamel JF
    Arch Fr Pediatr; 1988 Nov; 45(9):649-51. PubMed ID: 3069071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
    Laboudi A; Makdassi R; Cordonnier C; Fournier A; Choukroun G
    Nephrologie; 2002; 23(7):343-7. PubMed ID: 12500420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.